PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis

Oncogene

Volumn 33, Issue 25, 2014, Pages 3277-3287

  Guo, Q ^a   Su, N ^a   Zhang, J ^a   Li, X ^a   Miao, Z ^b   Wang, G ^a   Cheng, M ^c   Xu, H ^b   Cao, L ^a   Li, F ^a  

^a Department of Cell Biology Key Laboratory of Cell Biology Key Laboratory of Medical Cell Biology   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

gastric cancer; metastasis; PAK4; phosphorylation; SCG10

Indexed keywords

LCH 7749944; MICROTUBULE PROTEIN; P21 ACTIVATED KINASE 4; PROTEIN KINASE INHIBITOR; PROTEIN SCG10; SERINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CELL MIGRATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; METASTASIS; MICROTUBULE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR INVASION; TUMOR XENOGRAFT;

ANIMALS; CDC42 GTP-BINDING PROTEIN; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HEK293 CELLS; HEPATOCYTE GROWTH FACTOR; HETEROGRAFTS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICROTUBULES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; P21-ACTIVATED KINASES; PHOSPHORYLATION; SERINE; STOMACH NEOPLASMS;

EID: 84908028103     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.296     Document Type: Article

References (42)

1. Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003; 3: 55-63.
2. Kumar R, Gururaj AE, Barnes CJ. p21-activated kinases in cancer. Nat Rev Cancer 2006; 6: 459-471.
3. Abo A, Qu J, Cammarano MS, Dan C, Fritsch A, Baud V et al. PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J 1998; 17: 6527-6540.
4. Li X, Minden A. PAK4 functions in tumor necrosis factor (TNF) alpha-induced survival pathways by facilitating TRADD binding to the TNF receptor. J Biol Chem 2005; 280: 41192-41200.
5. Wells CM, Whale AD, Parsons M, Masters JR, Jones GE. PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion. J Cell Sci 2010; 123: 1663-1673.
6. Qu J, Cammarano MS, Shi Q, Ha KC, de Lanerolle P, Minden A. Activated PAK4 regulates cell adhesion and anchorage-independent growth. Mol Cell Biol 2001; 21: 3523-3533.
7. Zhang H, Li Z, Viklund EK, Stromblad S. P21-activated kinase 4 interacts with integrin alpha v beta 5 and regulates alpha v beta 5-mediated cell migration. J Cell Biol 2002; 158: 1287-1297.
8. Li X, Ke Q, Li Y, Liu F, Zhu G, Li F. DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1. Int J Biochem Cell Biol 2010; 42: 70-79.
9. Whale AD, Dart A, Holt M, Jones GE, Wells CM. PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity. Oncogene 2013; 32: 2114-2120.
10. Paliouras GN, Naujokas MA, Park M. Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor. Mol Cell Biol 2009; 29: 3018-3032.
11. Liu Y, Chen N, Cui X, Zheng X, Deng L, Price S et al. The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis. Oncogene 2010; 29: 5883-5894.
12. Callow MG, Clairvoyant F, Zhu S, Schryver B, Whyte DB, Bischoff JR et al. Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J Biol Chem 2002; 277: 550-558.
13. Kim JH, Kim HN, Lee KT, Lee JK, Choi SH, Paik SW et al. Gene expression profiles in gallbladder cancer: the close genetic similarity seen for early and advanced gallbladder cancers may explain the poor prognosis. Tumour Biol 2008; 29: 41-49.
14. Siu MK, Chan HY, Kong DS, Wong ES, Wong OG, Ngan HY et al. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc Natl Acad Sci USA 2010; 107: 18622-18627.
15. Liu Y, Xiao H, Tian Y, Nekrasova T, Hao X, Lee HJ et al. The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice. Mol Cancer Res 2008; 6: 1215-1224.
16. Begum A, Imoto I, Kozaki K, Tsuda H, Suzuki E, Amagasa T et al. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma. Cancer Sci 2009; 100: 1908-1916.
17. Tararuk T, Ostman N, Li W, Bjorkblom B, Padzik A, Zdrojewska J et al. JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J Cell Biol 2006; 173: 265-277.
18. Charbaut E, Curmi PA, Ozon S, Lachkar S, Redeker V, Sobel A. Stathmin family proteins display specific molecular and tubulin binding properties. J Biol Chem 2001; 276: 16146-16154.
19. Mori N, Morii H. SCG10-related neuronal growth-associated proteins in neural development, plasticity, degeneration, and aging. J Neurosci Res 2002; 70: 264-273.
20. Grenningloh G, Soehrman S, Bondallaz P, Ruchti E, Cadas H. Role of the microtubule destabilizing proteins SCG10 and stathmin in neuronal growth. J Neurobiol 2004; 58: 60-69.
21. Westerlund N, Zdrojewska J, Padzik A, Komulainen E, Bjorkblom B, Rannikko E et al. Phosphorylation of SCG10/stathmin-2 determines multipolar stage exit and neuronal migration rate. Nat Neurosci 2011; 14: 305-313.
22. Paradis V, Dargere D, Bieche Y, Asselah T, Marcellin P, Vidaud M et al. SCG10 expression on activation of hepatic stellate cells promotes cell motility through interference with microtubules. Am J Pathol 2010; 177: 1791-1797.
23. Togano T, Kurachi M, Watanabe M, Grenningloh G, Igarashi M. Role of Ser50 phosphorylation in SCG10 regulation of microtubule depolymerization. J Neurosci Res 2005; 80: 475-480.
24. Stein R, Mori N, Matthews K, Lo LC, Anderson DJ. The NGF-inducible SCG10 mRNA encodes a novel membrane-bound protein present in growth cones and abundant in developing neurons. Neuron 1988; 1: 463-476.
25. Bieche I, Maucuer A, Laurendeau I, Lachkar S, Spano AJ, Frankfurter A et al. Expression of stathmin family genes in human tissues: non-neural-restricted expression for SCLIP. Genomics 2003; 81: 400-410.
26. Wells CM, Abo A, Ridley AJ. PAK4 is activated via PI3K in HGF-stimulated epithelial cells. J Cell Sci 2002; 115: 3947-3956.
27. Ahmed T, Shea K, Masters JR, Jones GE, Wells CM. A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF. Cell Signal 2008; 20: 1320-1328.
28. Belletti B, Nicoloso MS, Schiappacassi M, Berton S, Lovat F, Wolf K et al. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell 2008; 19: 2003-2013.
29. Ahn HK, Jang J, Lee J, Se Hoon P, Park JO, Park YS et al. P21-activated kinase 4 overexpression in metastatic gastric cancer patients. Transl Oncol 2011; 4: 345-349.
30. Callow MG, Zozulya S, Gishizky ML, Jallal B, Smeal T. PAK4 mediates morphological changes through the regulation of GEF-H1. J Cell Sci 2005; 118: 1861-1872.
31. Mak GW, Chan MM, Leong VY, Lee JM, Yau TO, Ng IO et al. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis. Cancer Res 2011; 71: 2949-2958.
32. Zhang HJ, Siu MK, Yeung MC, Jiang LL, Mak VC, Ngan HY et al. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma. Carcinogenesis 2011; 32: 765-771.
33. Schaefer AW, Kabir N, Forscher P. Filopodia and actin arcs guide the assembly and transport of two populations of microtubules with unique dynamic parameters in neuronal growth cones. J Cell Biol 2002; 158: 139-152.
34. Palazzo AF, Gundersen GG. Microtubule-actin cross-talk at focal adhesions. Sci STKE 2002; 2002: pe31.
35. Jeon TY, Han ME, Lee YW, Lee YS, Kim GH, Song GA et al. Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells. Br J Cancer 2010; 102: 710-718.
36. Ghosh R, Gu R, Tillman E, Yuan J, Wang Y, Fazli L et al. Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression. Prostate 2007; 67: 1038-1052.
37. Takahashi M, Yang XJ, Lavery TT, Furge KA, Williams BO, Tretiakova M et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res 2002; 62: 6598-6605.
38. Chen G, Wang H, Gharib TG, Huang CC, Thomas DG, Shedden KA et al. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics 2003; 2: 107-116.
39. Li N, Jiang P, Du W, Wu Z, Li C, Qiao M et al. Siva1 suppresses epithelialmesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules. Proc Natl Acad Sci USA 2011; 108: 12851-12856.
40. Zhang J, Wang J, Guo Q, Wang Y, Zhou Y, Peng H et al. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells. Cancer Lett 2012; 317: 24-32.
41. Li Y, Shao Y, Tong Y, Shen T, Zhang J, Li Y et al. Nucleo-cytoplasmic shuttling of PAK4 modulates beta-catenin intracellular translocation and signaling. Biochim Biophys Acta 2012; 1823: 465-475.
42. McCarty Jr KS, Szabo E, Flowers JL, Cox EB, Leight GS, Miller L et al. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 1986; 46(8 Suppl): 4244s-4248s.